Medical journal The Lancet issued a correction on a large observational study that linked the use of antimalarial drug hydroxychloroquine with increased death risk in Covid-19 patients, after more ...

NEW DELHI: The Lancet, one of the world’s most prestigious medical journals, has retracted a major study that had claimed that experimental treatment of COVID-19 patients with malaria drugs ...

Bengaluru: A recent research study published in Lancet on antimalarial drug hydroxychloroquine (HCQ), used to treat Covid-19 patients, not offering any benefit has led to debate on the use of the drug ...

Lancet medical journal issued an official "expression of concern" on Tuesday regarding a study published by it last month on the effects of Hydroxychloroquine (HCQ) in the treatment of COVID-19 ...

New Delhi: The authors of a controversial study published in The Lancet journal linking the use of malaria drug hydroxychloroquine with increased death risk in COVID-19 patients, have retracted their ...

A recent research study published in Lancet on antimalarial drug hydroxychloroquine (HCQ), used to treat Covid-19 patients, not offering any benefit has led to debate on the use of the drug. Lancet is ...

NEW DELHI: The Lancet Journal late on Thursday retracted the controversial study on hydroxychloroquine which said the repurposed anti-malaria drug increased the risk of mortality in covid-19 patients ...

'WHO has been under a lot of attack, so when they saw the Lancet study, they stopped the clinical trials of HCQ.' 'They should not have stopped the clinical trials.' Kindly note the image has been ...

The flip-flop over hydroxychloroquine continued on Wednesday with The Lancet issuing an “expression of concern” about a study that prompted the World Health Organization to halt tests with the ...

London, May 30 : Medial journal The Lancet issued a correction on a large observational study that linked use of anti-malarial drug hydroxychloroquine with increased death risk in Covid-19 patients, ...